G Peirano, L Chen, BN Kreiswirth… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent …
SE Heiden, NO Hübner, JA Bohnert, CD Heidecke… - Genome Medicine, 2020 - Springer
Abstract Background Antibiotic-resistant Klebsiella pneumoniae are a major cause of hospital-and community-acquired infections, including sepsis, liver abscess, and …
ABSTRACT Ceftazidime-avibactam (CAZ-AVI) is a promising novel treatment for infections caused by carbapenem-resistant Enterobacteriaceae (CRE). Despite improved treatment …
Objectives Recent reports indicate the emergence of a new carbapenemase-producing Klebsiella pneumoniae clone, ST307. We sought to better understand the global …
ABSTRACT From January 2019 to April 2020, 32 KPC-producing, ceftazidime-avibactam (CZA)-resistant Klebsiella pneumoniae strains were isolated in a university hospital in …
T Tesfa, H Mitiku, M Edae, N Assefa - Systematic reviews, 2022 - Springer
Background Klebsiella pneumoniae is a gram-negative rod belonging to the order Enterobacterales and having a wide distribution in the environment, including the human …
WP Herridge, P Shibu, J O'Shea… - Journal of medical …, 2020 - microbiologyresearch.org
Klebsiella spp. are commensals of the human microbiota, and a leading cause of opportunistic nosocomial infections. The incidence of multidrug resistant (MDR) strains of …
Background Klebsiella pneumoniae is a leading cause of extended-spectrum β-lactamase (ESBL)–producing hospital-associated infections, for which elderly patients are at increased …
Background Resistance to third-generation cephalosporins, often mediated by extended- spectrum beta-lactamases (ESBLs), is a considerable issue in hospital-associated infections …